background
sinc
decemb
coronaviru
diseas
patient
confirm
global
base
posit
viral
nucleic
acid
realtim
revers
transcriptasepolymeras
chain
reaction
rtpcr
howev
associ
clinic
laboratori
ct
characterist
rtpcr
result
still
unclear
sought
examin
associ
detail
especi
recov
patient
outbreak
novel
coronaviru
diseas
emerg
wuhan
china
spread
quickli
across
countri
around
world
march
word
health
organ
made
assess
character
pandem
surpass
confirm
case
worldwid
death
accord
recommend
guidelin
approxim
patient
discharg
china
two
consecut
neg
realtim
polymeras
chain
reaction
rtpcr
result
nucleic
acid
adequ
approv
avail
altern
emerg
use
rtpcr
diagnos
thu
nucleic
acid
test
play
import
key
role
diagnosi
therapeut
decisionmak
apart
rtpcr
result
new
coronaviru
pneumonia
observ
approxim
patient
chest
ct
imag
although
epidemiolog
clinic
laboratori
ct
characterist
well
document
associ
rtpcr
result
still
unclear
recent
followup
examin
found
patient
posit
rtpcr
result
recoveri
howev
followup
recov
patient
limit
date
sought
assess
associ
rtpcr
result
clinic
laboratori
radiolog
featur
patient
specif
evalu
clinic
characterist
patient
reposit
rtpct
test
result
recoveri
singlecentr
studi
retrospect
recruit
patient
diagnos
jan
feb
chengdu
public
health
clinic
medic
center
hospit
special
infecti
diseas
also
design
hospit
emerg
chengdu
china
inclus
criteria
follow
patient
laboratoryconfirm
infect
rtpcr
result
patient
discharg
hospit
standard
treatment
two
consecut
neg
rtpcr
result
base
sixth
guidelin
cdc
china
patient
die
discharg
exclud
institut
ethic
board
institut
approv
studi
patient
oral
inform
clinic
data
would
use
perform
research
contribut
deeper
understand
privat
inform
would
strictli
confidenti
rtpcr
result
recoveri
track
due
date
feb
seri
thinsect
chest
ct
scan
perform
gebrightspe
spiral
ct
detector
slice
thick
mm
imag
acquir
endinhal
breathhold
condit
scan
rang
cover
area
angl
costal
diaphragm
base
lung
entranc
chest
standard
lung
window
window
level
hu
window
width
hu
mediastin
window
window
level
hu
window
width
hu
use
imag
assess
two
train
radiologist
least
year
experi
cardiothorac
imag
blind
clinic
inform
review
ct
imag
enrol
subject
independ
third
cardiothorac
radiologist
year
experi
refer
disagr
encount
seri
ct
scan
evalu
presenc
follow
characterist
groundglass
opac
consolid
mix
groundglass
opac
vascular
enlarg
interlobular
septal
thicken
reticul
number
involv
lobe
progress
improv
lesion
lobe
medic
record
review
care
data
collect
standard
form
data
record
includ
demograph
epidem
inform
symptom
sign
treatment
strategi
complic
underli
comorbid
subtyp
novel
coronaviru
pneumonia
ncp
data
laboratori
test
also
record
includ
blood
count
crp
level
coagul
cardiac
marker
liver
function
renal
function
peripher
blood
lymphocyt
subset
date
neg
rtpcr
result
defin
day
first
two
consecut
neg
rtpcr
result
date
diseas
onset
defin
day
symptom
sign
first
identifi
ncp
classifi
mild
common
sever
critic
sever
subtyp
accord
guidelin
cdc
china
continu
variabl
present
mean
standard
differ
sd
median
interquartil
rang
iqr
categor
variabl
present
frequenc
percentag
continu
variabl
compar
use
match
group
anova
independ
test
normal
distribut
match
group
friedman
wilcoxon
sign
rank
test
p
consid
statist
signific
analys
perform
offlin
softwar
spss
version
intern
busi
machin
armonk
new
york
usa
total
laboratoryconfirm
patient
discharg
hospit
enrol
basic
clinic
character
shown
tabl
median
age
iqr
year
patient
age
year
patient
male
patient
live
wuhan
recent
travel
wuhan
portion
expos
patient
case
unknown
origin
median
interv
diseas
onset
admiss
day
iqr
fever
common
symptom
fatigu
dri
cough
expector
etc
also
found
half
patient
common
ncp
sever
critic
sever
ncp
patient
receiv
antibiot
treatment
tradit
chines
medicin
necessari
three
patient
need
intens
unit
care
patient
requir
noninvas
mechan
ventil
highflow
oxygen
therapi
three
patient
develop
acut
respiratori
distress
syndrom
patient
type
respiratori
failur
laboratori
test
result
admiss
shown
tabl
white
blood
cell
count
neutrophil
count
normal
rang
patient
fifteen
patient
reduc
lymphocyt
count
remain
patient
count
within
normal
rang
term
crp
patient
increas
level
admiss
except
patient
radiograph
sign
admiss
accord
chest
ct
shown
tabl
initi
ct
examin
patient
normal
chest
ct
result
patient
bilater
infect
patient
unilater
infect
lower
lobe
lung
higher
incid
involv
case
involv
right
lower
lobe
case
involv
left
lower
lobe
ggo
common
find
accompani
sign
includ
consolid
mix
ggo
interlobular
septal
thicken
vascular
enlarg
reticul
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
compar
laboratori
test
result
differ
time
shown
tabl
found
indic
chang
significantli
p
except
lymphocyt
count
crp
level
peripher
blood
lymphocyt
subset
lymphocyt
count
median
l
iqr
increas
obvious
obtain
neg
rtpcr
result
p
addit
count
count
count
increas
significantli
obtain
neg
rtpcr
result
p
furthermor
obtain
neg
rtpcr
result
crp
level
decreas
mgl
vs
mgl
vs
mgl
nevertheless
patient
still
elev
crp
level
obtain
neg
rtpcr
result
among
enrol
subject
patient
underw
chest
ct
three
time
includ
exam
admiss
well
obtain
neg
rtpcr
result
detail
radiograph
sign
list
tabl
median
recoveri
day
rang
day
patient
repeat
posit
rtpcr
result
readmit
hospit
dynam
ct
characterist
reposit
patient
list
tabl
supplementari
appendix
regard
rd
ct
find
neg
rtpcr
result
discharg
improv
observ
patient
case
case
case
case
figur
progress
observ
patient
case
figur
case
figur
regard
chest
ct
find
patient
reposit
rtpcr
result
time
readmiss
hospit
new
ggo
present
patient
case
case
figur
patient
improv
greatli
figur
addit
readmiss
crp
level
increas
patient
case
case
lymphocyt
count
decreas
case
figur
humantohuman
transmiss
found
patient
reposit
rtpcr
result
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
studi
analys
dynam
variat
clinic
featur
laboratori
test
ct
imag
well
associ
rtpcr
result
notabl
investig
case
seri
patient
reposit
rtpcr
result
nucleic
acid
recoveri
essenti
manag
research
found
follow
result
crp
level
lymphocyt
count
main
signific
laboratori
index
obtain
neg
rtpcr
result
crp
level
continu
decreas
half
patient
still
level
higher
normal
rang
lymphocyt
count
patient
increas
obvious
usual
recov
normal
rang
obtain
neg
rtpcr
result
among
patient
ggo
patient
common
find
chest
ct
frequent
occur
bilater
lung
multilobular
infect
importantli
obtain
neg
rtpcr
result
patient
demonstr
segment
progress
ct
rtpcr
result
posit
discharg
day
day
discharg
patient
patient
reposit
rtpcr
result
day
discharg
two
found
new
ggo
remain
patient
improv
compar
ct
find
neg
rtpcr
result
thu
followup
rtpcr
chest
ct
necessari
especi
recov
patient
human
coronaviru
mainli
affect
respiratori
system
caus
mild
moder
respiratori
symptom
ie
hcovhku
sever
acut
respiratori
syndrom
sarscov
merscov
although
sequenc
rel
differ
two
highli
pathogen
coronavirus
sarscov
merscov
threaten
public
health
may
share
similar
regard
pathogenesi
chemokin
cytokin
might
play
key
role
human
coronaviru
infect
indirect
evid
show
second
phase
sarscov
infect
high
fever
obviou
progress
pneumonia
hypoxemia
occur
despit
signific
declin
viru
titr
addit
previou
research
sarscov
merscov
directli
reveal
proinflammatori
cytokin
chemokin
serum
increas
consider
antiinflammatori
cytokin
decreas
sever
patient
similar
phenomenon
observ
proinflammatori
cytokin
increas
icu
patient
much
higher
plasma
concentr
cytokin
storm
immunopatholog
via
dysregul
chemokin
cytokin
may
caus
epitheli
endotheli
cell
apoptosi
vascular
leakag
infiltr
macrophag
neutrophil
induc
sever
lung
injuri
similarli
studi
demonstr
patient
sustain
increas
crp
level
decreas
lymphocyt
count
patient
ct
imag
demonstr
progress
rtpcr
result
becam
neg
suggest
patient
may
suffer
inflammatori
storm
lymphat
system
especi
lymphocyt
injuri
caus
viru
addit
serum
level
chemokin
cytokin
might
remain
elev
lead
inflammatori
respons
even
neg
rtpcr
result
may
reason
progress
radiograph
sign
patient
figur
figur
fact
almost
half
patient
still
higher
crp
level
obtain
neg
rtpcr
result
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
evid
previou
studi
indic
period
time
need
reduc
inflammatori
respons
research
sarscov
demonstr
day
recoveri
sarscov
inflammatori
factor
still
higher
normal
control
pneumonia
still
exist
lung
complet
resolut
may
occur
day
later
thu
patient
discharg
hospit
regular
followup
laboratori
test
ct
imag
essenti
monitor
inflamm
progress
reduct
suffici
nutrit
support
necessari
help
repair
inflammatori
injuri
previou
radiograph
studi
shown
major
patient
similar
ct
characterist
ggo
consolid
fibrosi
improv
patient
fibrosi
resolut
exud
detect
howev
new
lesion
addit
consolid
primari
lesion
found
progress
patient
research
found
patient
reposit
rtpcr
result
day
discharg
patient
chest
ct
result
reposit
patient
show
lung
lesion
deterior
compar
chest
ct
result
obtain
neg
rtpcr
result
one
patient
new
lesion
lung
followup
chest
ct
readmit
hospit
due
reposit
rtpcr
result
result
demonstr
even
neg
rtpcr
result
nasopharyng
swab
patient
lesion
progress
ct
imag
given
attent
phenomenon
may
due
two
reason
one
proport
recov
patient
may
still
carri
viru
thu
close
observ
quarantin
need
two
week
discharg
base
consider
isol
day
ad
guidelin
issu
china
nation
health
commiss
anoth
reason
may
patient
underw
nasopharyng
swab
test
may
provid
falseneg
result
due
sampl
bia
therefor
two
round
neg
rtpcr
result
recommend
criteria
recoveri
combin
dynam
chest
ct
essenti
mention
sixth
edit
patient
manag
guidelin
addit
patient
neg
rtpcr
result
ct
progress
deep
sampl
lower
respiratori
tract
faecal
sampl
requir
ensur
neg
rtpcr
result
accur
accord
research
latest
literatur
chest
ct
play
critic
role
evalu
ncp
progress
well
followup
rtpcr
result
becom
neg
thu
chest
ct
find
consid
part
standard
criteria
discharg
manag
futur
effort
made
investig
viru
retent
ct
outcom
clinic
prognosi
studi
limit
first
rel
small
number
recov
patient
includ
patient
three
followup
ct
imag
second
time
followup
rel
short
full
outcom
rtpcr
result
may
limit
extent
third
result
proinflammatori
cytokin
chemokin
lack
evid
need
regard
sustain
inflammatori
condit
obtain
neg
rtpcr
result
thu
investig
consid
abovement
limit
requir
heterogen
ct
featur
rtpcr
result
found
especi
recov
patient
obtain
neg
rtpcr
result
studi
highlight
rtpcr
chest
ct
consid
key
determin
clinic
diagnosi
manag
patient
discharg
criteria
furthermor
longterm
followup
studi
essenti
patient
obtain
neg
rtpcr
result
especi
patient
sustain
abnorm
index
progress
chest
ct
manifest
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
group
neg
pcr
group
neg
rtpcr
result
mean
statist
signific
group
admiss
group
neg
rtpcr
result
mean
statist
signific
group
admiss
group
neg
rtpcr
result
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
